Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

IMCgp100 in Advanced Unresectable Melanoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01209676
First received: September 22, 2010
Last updated: November 11, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)